Table 1 Baseline anthropometric and biochemical characteristics.

From: Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome

 

PCOS (n = 1044)

Control (n = 366)

BMI < 25 (n = 350)

25 ≤ BMI < 30 (n = 312)

BMI ≥ 30 (n = 382)

BMI < 25 (n = 203)

25 ≤ BMI < 30 (n = 32)

BMI ≥ 30 (n = 131)

Age (y)

26.0 (22.0, 30.0)

27.0 (22.0, 31.0)

26.0 (21.0–30.0)

26.0 (24.0, 32.0)

25.0 (20.0, 29.0)

25.0 (21.0, 30.0)

Weight (kg)

55.0 (51.0–60.0)ab

72.1 (68.5–77.1)ac

90.1 (84.0–100.6)bc

54.1 (51.4–58.0)

74.9 (69.3, 80.0)

91.0 (85.0–101.1)

BMI (kg/m2)

21.5 (19.6, 23.2)ab

27.6 (26.2, 29.0)ac

33.9 (31.9, 37.1)bc

21.0 (20.0, 22.2)

28.3 (25.1, 29.2)

33.7 (32.0, 37.4)

Waist (cm)

74.0 (68.0, 80.0)abd

91.0 (86.0, 95.0)ac

104.9 (99.0, 113.5)bc

73.0 (68.0, 79.0)d

91.25 (84.5, 95.0)

104.0 (98.0, 110.3)

Hip (cm)

92.0 (88.0, 95.0)ab

103.0 (100.0, 106.0)ac

112.3 (107.0, 119.6)bc

90.8 (88.0, 94.0)

104.5 (99.25, 109.0)

114.0 (107.5, 120.0)

WHR

0.81 (0.76, 0.86)abd

0.88 (0.84, 0.92)ac

0.93 (0.89, 0.99)bc

0.79 (0.74, 0.83)d

0.87 (0.83, 0.91)

0.91 (0.86, 0.96)

ALT(IU/L)

14.0 (11.0, 22.0)abd

23.0 (15.0, 47.0)ace

37.0 (23.0, 57.5)bcf

13.0 (11.0, 15.0)d

17.0 (12.5, 26.5)e

25.0 (19.0, 47.0)f

AST(IU/L)

17.0 (14.0, 21.8)ab

21.0 (16.0, 33.0)ac

25.0 (19.0, 35.0)bd

18.0 (16.0, 20.0)

18.0 (14.5, 21.0)c

21.0 (17.0, 28.0)d

ALP(IU/L)

51.0 (44.0, 62.0)a

58.0 (48.0, 75.0)

62.0 (55.0, 70.0)

45.0 (36.0, 52.0)a

54.0 (40.5, 67.0)

62.0 (52.0, 76.0)

GGT(IU/L)

13.0 (10.0, 18.0)ab

22.0 (15.0, 34.0)acd

27.0 (18.0, 42.0)bce

13.0 (10.8, 17.0)

15.0 (11.0, 17.0)d

20.0 (15.0, 32.0)e

TG(mmol/L)

0.88 (0.66, 1.26)abc

1.42 (1.04, 1.99)ad

1.48 (1.13, 2.11) b

0.72 (0.58, 0.96)c

0.90 (0.72, 1.28)d

1.29 (1.03, 1.96)

TC(mmol/L)

4.33 (3.61, 4.95)a

4.54 (3.83, 5.28)

4.66 (4.02, 5.24)a

4.41 (3.88, 4.87)

4.66 (4.09, 5.15)

4.57 (4.04, 5.09)

HDL(mmol/L)

1.40 (1.07, 1.67)ab

1.10 (0.89, 1.34)acd

1.05 (0.93, 1.25)bc

1.51 (1.34, 1.66)

1.33 (1.17, 1.66)d

1.11 (0.96, 1.25)

LDL(mmol/L)

2.28 (1.79, 2.91)abc

2.69 (2.06, 3.20)a

2.89 (2.32, 3.35)b

2.52 (2.04, 2.93)c

2.72 (2.28, 3.17)

2.77 (2.37, 3.35)

FPG (mmol/L)

4.72 (4.50, 5.10)ab

5.00 (4.60, 5.40)ac

5.25 (4.81, 5.81)bc

4.83 (4.55, 5.00)

5.12 (4.80, 5.40)

5.20 (4.87, 5.29)

2hPG (mmol/L)

6.30 (5.38, 7.39)abd

7.30 (6.05, 9.04)ac

7.80 (6.54, 9.70)bc

5.42 (4.83, 6.24)d

6.80 (5.90, 8.22)

7.34 (6.18, 8.80)

HOMA-IR

1.91 (1.06, 3.45)abd

3,22 (1.95, 5.11)ac

5.28 (3.54, 7.71)bce

1.47 (1.11, 2.02)d

3.09 (2.16, 5.75)

4.34 (3.09, 6.20)e

  1. Data are presented as median (25,75 percentile). FPG: fasting plasma glucose; 2hPG:2-hour plasma glucose. abcdefThe same superscripts indicate a statistically significant difference (P < 0.05) between pairs.